Igm Biosciences Inc (IGMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2019 | 12-2018 | 09-2018 | 12-2017 | |
| Operating Expenses | 7,357 | 0 | 6,545 | 0 |
| Operating Income | -7,357 | N/A | -6,545 | N/A |
| Other Income | -113 | 0 | 28 | 0 |
| Pre-tax Income | -7,470 | 0 | -6,517 | 0 |
| Net Income Continuous | -7,470 | N/A | -6,517 | N/A |
| Net Income | $-7,470 | $N/A | $-6,517 | $N/A |
| EPS Basic Total Ops | -16.86 | N/A | -14.88 | N/A |
| EPS Basic Continuous Ops | -16.86 | N/A | -14.88 | N/A |
| EPS Diluted Total Ops | -16.86 | N/A | -14.88 | N/A |
| EPS Diluted Continuous Ops | -16.86 | N/A | -14.88 | N/A |
| EBITDA(a) | $-7,243 | $N/A | $-6,545 | $N/A |